Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000473335 | SCV000555821 | likely benign | Bloom syndrome | 2024-12-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000570671 | SCV000672885 | likely benign | Hereditary cancer-predisposing syndrome | 2018-05-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV000570671 | SCV002532500 | likely benign | Hereditary cancer-predisposing syndrome | 2021-03-08 | criteria provided, single submitter | curation | |
Ce |
RCV003392288 | SCV004130913 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | BLM: BP4, BP7 |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV003392288 | SCV004222484 | likely benign | not provided | 2022-12-13 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000473335 | SCV001462153 | uncertain significance | Bloom syndrome | 2020-01-24 | no assertion criteria provided | clinical testing |